Vitestro: A team on a mission to redefine diagnostic blood collection
We’re a Netherlands-based medical robotics company combining engineering with clinical expertise. Together with hospitals and labs, we’re launching Aletta®, the one and only Autonomous Robotic Phlebotomy Device™.
We transform patient care globally by setting the new standard for safe, reliable, and efficient diagnostic blood collection.
Engineered by experts
We are a multidisciplinary team united by one purpose: to transform diagnostic blood collection with autonomous technology.
Vitestro brings seasoned engineers, clinicians, and industry experts together. This multidisciplinary team develops and improves Aletta®, ensuring our technology meets the needs of patients and healthcare professionals.
Created with healthcare experts
We work closely with hospitals and labs so Aletta meets the needs of phlebotomy departments.
Aletta is developed in collaboration with clinical partners and informed by insights from trials and real practice. This approach helps ensure quality, ease of use, and a positive experience for patients and healthcare professionals.
The founding story of Vitestro
The idea for Vitestro began when Toon Overbeeke and Brian Joseph shared their frustrations about the experience with blood draws from their loved ones. In Toon’s case, a friend’s father was difficult to puncture due to chemotherapy. Brian faced long wait times and logistical errors when one of his children needed regular blood tests.
These personal experiences started a discussion about the opportunity to improve blood collection. The founders saw an opportunity to create autonomous technology that offers accurate, convenient blood collection while improving the patient experience. In 2017, they took the leap and founded Vitestro.
Since then, Vitestro has grown into a team of nearly 100 employees. In August 2024, Aletta® received CE mark approval, a major step toward making autonomous blood collection accessible to everyone.
Our Leadership Team
Toon Overbeeke is the co-founder and CEO of Vitestro. When observing challenges in blood drawing, Toon directly realized that this procedure could be transformed with technology. He teamed up with Brian and together they founded Vitestro in 2017.
Brian Joseph is co-founder of Vitestro and focuses on product management, after building commercial activities. Previously, he co-founded open-source software company Zarafa and served as its CEO until the company was acquired by Amazon in 2013.
Bob brings over 30 years of leadership experience in the medical technology and diagnostic sectors. Bob leads the global pre-launch market development, commercial strategy, and execution, driving the adoption of Vitestro’s technology across the European and U.S. healthcare market.
Andy is a former partner of Sonder Capital. After working closely with our team as an investor and board member, Andy has decided to step away from his previous role to fully immerse himself in helping us drive Vitestro’s vision forward.
Dewi Hamwijk-Habermehl is Head of People, Culture & Legal at Vitestro, responsible for HR. She started her career at Allen & Overy and worked for Donahue & Partners LLP in New York City. Then she became COO of a startup company, The Social Handshake, before joining Vitestro in 2022.
Jasmine Beukema is Head of Quality Assurance and Regulatory Affairs (QA/RA) at Vitestro, responsible for MDR and FDA clearance. With over 15 years of experience in QA/RA, Jasmine set up several quality management systems from scratch.
Luuk Giesen is CMO of Vitestro, responsible for clinical strategy and clinical affairs. He completed his MD degree at the University of Amsterdam-AMC and worked as a physician in internal medicine. Luuk joined Vitestro as one of its first employees in 2018.
Jim Lelivelt is CFO at Vitestro, responsible for finance and fundraising. He brings over 15 years of experience, having started his career in London in investment banking at HSBC and in private equity, before moving into consulting at McKinsey & Company. Jim joined Vitestro in 2021.
Bas Nieuwenhuis is the VP of Engineering of Vitestro. Bas brings over 25+ years of experience in product development, including leadership roles at Movacolor and at BD Kiestra, where he led the R&D team in scaling and innovating a portfolio of medical devices and software.
Our vision & mission
Vision
Autonomous vascular access as the global standard of care, available to all patients.
Mission
We pioneer and commercialize autonomous robotic phlebotomy by combining multimodal imaging and artificial intelligence, with the ambition to make Aletta the default method for diagnostic blood collection worldwide.
Some of our open positions
Position
Contract
Start date
We are looking for a Product Owner to join the Platform Team and maximize the value delivered by Vitestro’s Cloud & Connectivity Platform.
We are looking for a Cloud Engineer to join the Platform Team and help build the cloud foundations that power Vitestro’s Cloud & Connectivity Platform.
We are looking for a supervisor at the phlebotomy department. You will guide patients with the use of Aletta, register study data, and perform checks on the device.
Our board
Fred Moll
Non-executive board member
Sjaak Deckers
Non-executive board member
Jeroen Hegge
Non-executive board member
Dave Hickey
Non-executive board member
Let's get in touch
Do you have questions or want to learn more about Aletta®? Our team is ready to help you explore how Aletta can support your laboratory and improve patient care.